Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
BAISHIDENG PUBLISHING GROUP INC
Citação
WORLD JOURNAL OF CLINICAL CASES, v.10, n.23, p.8422-8424, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We performed a literature mini-review of the clinical profile of patients with spondylarthritis who are also human leukocyte antigen (HLA)-B51-positive. It seems to us that patients with HLA-B27 and HLA-B51 are more common in men, Asians and between the third and ninth decades of life. They are more likely to develop peripheral joint conditions, with cutaneous manifestations (e.g., oral ulcers) and uveitis. Therefore, more robust epidemiological studies with more accurate methodology and multicenter locations are needed to better map the role of the interaction between HLA-B51 in patients with spondylarthritis.
Palavras-chave
HLA-B27, HLA-B51, Ankylosing spondylitis, Spondylarthritis, Human leukocyte antigen
Referências
  1. Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3
  2. Chang HK, 2002, J KOREAN MED SCI, V17, P524, DOI 10.3346/jkms.2002.17.4.524
  3. Chen LY, 2017, ANN RHEUM DIS, V76, P593, DOI 10.1136/annrheumdis-2016-209512
  4. Greco A, 2018, AUTOIMMUN REV, V17, P567, DOI 10.1016/j.autrev.2017.12.006
  5. Jung JH, 2019, ANN ACAD MED SINGAP, V48, P321
  6. Kobayashi S, 2000, INTERNAL MED, V39, P89, DOI 10.2169/internalmedicine.39.89
  7. Lim MJ, 2022, WORLD J CLIN CASES, V10, P992, DOI 10.12998/wjcc.v10.i3.992
  8. MINESHITA S, 1992, INTERNAL MED, V31, P1073, DOI 10.2169/internalmedicine.31.1073
  9. Mizuki N, 2001, TISSUE ANTIGENS, V58, P181, DOI 10.1034/j.1399-0039.2001.580306.x
  10. Prete M, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/s12348-014-0017-9
  11. Shimamoto Y, 2000, INTERNAL MED, V39, P182, DOI 10.2169/internalmedicine.39.182
  12. Taniguchi Y, 2003, J INT MED RES, V31, P55, DOI 10.1177/147323000303100109